Eric Crombez Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

Eric Crombez is EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 71,922 shares of RARE, which is worth approximately $2.82 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 8,945 shares (Common Stock) at a price of $42.1 per share, resulting in proceeds of $376,584. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.9K

48.5% 3M change

47.0% 12M change

Total Value Held $2.82 Million

Eric Crombez Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2025	SELL Open market or private sale	$376,584 $42.1 p/Share	8,945 Reduced 11.06%	71,922 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	31,784 Added 28.38%	80,215 Common Stock
May 02 2024	SELL Open market or private sale	$15,455 $43.66 p/Share	354 Reduced 0.73%	48,431 Common Stock
Apr 18 2024	SELL Open market or private sale	$6,262 $44.1 p/Share	142 Reduced 0.29%	48,785 Common Stock
Mar 01 2024	SELL Open market or private sale	$66,554 $53.76 p/Share	1,238 Reduced 2.47%	48,927 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	19,400 Added 27.99%	49,912 Common Stock
May 01 2023	BUY Grant, award, or other acquisition	-	4,658 Added 13.24%	30,512 Common Stock

Also insider at

ABEO

ABEONA THERAPEUTICS INC. Healthcare

Director

Eric Crombez

EVP and Chief Medical Officer

Novato, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Value

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Track Activities on RARE

Account